Activity 4H. Sofosbuvir-Velapatasvir Treatment with Compensated Cirrhosis PDF Share Learning Objective Performance Indicators Provide a rationale for treating all people with HCV except persons with less than a 12-month life expectancy Adhere to inclusion and exclusion criteria for who is eligible to receive simplified HCV treatment Choose an appropriate recommended regimen for simplified HCV treatment Conduct laboratory monitoring for persons receiving simplified HCV treatment, including assessment for sustained virologic response Manage incomplete treatment adherence based on time into treatment and number of days of missed doses Activity QuestionYou should answer this question after completing the activity. You must answer all of the questions before checking your work. This activity has a Check on Learning question. - Show Question A 37-year-old man is newly diagnosed with hepatitis C virus (HCV) infection. The initial evaluation shows evidence of compensated cirrhosis with a Child-Pugh-Turcotte score of 5. He does not have diabetes mellitus, HIV, or chronic hepatitis B virus (HBV) infection. You are required by his health insurance contract to use sofosbuvir-velpatasvir. What is the next step that should be taken for this patient? Obtain an HCV genotype Treat with 16 weeks of sofosbuvir-velpatasvir Order an HCV drug resistance test Treat with a 12-week regimen of ledipasvir-sofosbuvir Share by e-mail From:Enter your e-mail address To: Enter the e-mail address of the recipient Your Message: Check-On-LearningQuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
